High Schoolers Make Martin Shkreli’s Pricey Drug on the Cheap

The one-time “most hated” man in the U.S. may have been foiled by a group of Australian students. Martin Shkreli rose to infamy in 2015 when his company, Turing Pharmaceuticals, raised the price of a drug called Daraprim from $13.50 to $750 per pill. The anti-parasitic drug is used by some patients with malaria or AIDS. Now, Shkreli, who is for many a symbol of greed, faces competition from a group of Australian high school students who developed 3.7 grams of the main active ingredient...

© La Voix de l'Amérique - jeudi 1^er décembre 2016